We are a Life Science company founded by scientists that develops innovative and fluorescence-based enzyme assay formats for a quantum improvement in performance and productivity. We apply rigorous development, validation and manufacturing practices to create products that deliver exceptional value (easier, faster, better, cheaper) with expert customer support.

At AssayQuant Technologies, Inc., we are actively developing next generation Sox Technology Sensors to meet the needs of our customers. These efforts incorporate improvements from the Imperiali laboratory, including the Cysteine-Sox method to create superior Sox-based substrates by allowing for flanking sequence recognition determinants on either side of the Sox moiety/phosphorylation site. We are applying this approach to generate both highly generic substrates (for use with a range of purified kinases) or highly-selective substrates (for use with unfractionated cell or tissue lysates; see Peterson et. al., 2014).